Univariable HR (95% CI) | Multivariablea HR (95% CI) – Overall | |
---|---|---|
Tumor type | ||
GCTs | Ref. | Ref. |
SCSTs | 2.96 (2.03–4.33)*** | 1.68 (1.13–2.49)* |
Age (per 5-year increase) | 1.21 (1.19–1.23)*** | 1.18 (1.16–1.20)*** |
Race/ethnicity | ||
Non-Hispanic White | Ref. | Ref. |
Non-Hispanic Black | 1.80 (1.41–2.29)*** | 1.13 (0.89–1.45) |
Hispanic/other | 1.27 (1.13–1.43)*** | 1.14 (1.01–1.30)* |
Insurance | ||
Private insurance | Ref. | Ref. |
Uninsured | 2.63 (2.29–3.01)*** | 2.32 (2.01–2.66)*** |
Medicaid/Medicare/other government insurance | 4.33 (3.88–4.83)*** | 2.72 (2.42–3.05)*** |
Income (per year) | ||
< $38,000 | Ref. | Ref. |
$38,000–$62,999 | 0.71 (0.62–0.81)*** | 0.94 (0.82–1.09) |
> $63,000 | 0.44 (0.38–0.50)*** | 0.76 (0.63–0.92)** |
Percent in ZIP code without a high school diploma | ||
> 21% | Ref. | Ref. |
7–20.9% | 0.63 (0.56–0.71)*** | 0.83 (0.73–0.96)* |
< 7% | 0.43 (0.37–0.49)*** | 0.74 (0.61–0.90)** |
Residence | ||
Metropolitan | Ref. | Ref. |
Urban/rural | 1.49 (1.33–1.67)*** | 1.13 (1.00–1.28) |
Charlson-Deyo comorbidity score | ||
0 | Ref. | Ref. |
≥ 1 | 3.23 (2.82–3.70)*** | 2.06 (1.79–2.37)*** |